IL22 and inflammatory bowel disease: compared intestinal Peyer’s patches (PP)-derived MSCs with bone marrow-derived MSCs and systematically demonstrated the prominent benefits of mouse MSC proteins in the treatment of inflammatory bowel disease (IBD) in mice, partly through IL-22 (112).